US FDA’s Current Technical Standards Not A Good Fit For Real-World Data, Stakeholders Say

Shoehorn
FDA is trying to shoehord real-world data into existing, but unsuitable, technical standards, industry comments say. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Real-World Evidence

More from Clinical Trials